Cargando…

N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer

The main protease (M(pro), also known as 3CL protease) of SARS-CoV-2 is a high priority drug target in the development of antivirals to combat COVID-19 infections. A feline coronavirus antiviral drug, GC376, has been shown to be effective in inhibiting the SARS-CoV-2 main protease and live virus gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arutyunova, Elena, Khan, Muhammad Bashir, Fischer, Conrad, Lu, Jimmy, Lamer, Tess, Vuong, Wayne, van Belkum, Marco J., McKay, Ryan T., Tyrrell, D. Lorne, Vederas, John C., Young, Howard S., Lemieux, M. Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061786/ https://www.ncbi.nlm.nih.gov/pubmed/33895266 http://dx.doi.org/10.1016/j.jmb.2021.167003

Ejemplares similares

Crystallization of Feline Coronavirus M(pro) With GC376 Reveals Mechanism of Inhibition
por: Lu, Jimmy, et al.
Publicado: (2022)

Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
por: Vuong, Wayne, et al.
Publicado: (2021)

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Vuong, Wayne, et al.
Publicado: (2020)

Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Vuong, Wayne, et al.
Publicado: (2020)

Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
por: Luan, Xiao-dong, et al.
Publicado: (2022)

Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
por: Sharun, Khan, et al.
Publicado: (2020)

Author Correction: Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
por: Luan, Xiao-dong, et al.
Publicado: (2022)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
por: Paciaroni, Alessandro, et al.
Publicado: (2023)

Simplified cloning and isolation of peptides from “sandwiched” SUMO-peptide-intein fusion proteins
por: Lamer, Tess, et al.
Publicado: (2023)

Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis
por: Lv, Jinbao, et al.
Publicado: (2022)

SARS-CoV-2 M(pro) Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals
por: Chen, Sizhu Amelia, et al.
Publicado: (2023)

Interaction of GC376, a SARS-COV-2 M(PRO) inhibitor, with model lipid membranes
por: Klacsová, Mária, et al.
Publicado: (2022)

A cysteine protease inhibitor GC376 displays potent antiviral activity against coxsackievirus infection
por: Chen, Yongkang, et al.
Publicado: (2023)

MINOS: Bt 376 - 599 ext - 376 ext - AP (100)
Publicado: (1991)

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
por: Fu, Lifeng, et al.
Publicado: (2020)

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022)

Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376
por: Ye, Gang, et al.
Publicado: (2020)

Travaux au bâtiment 376
Publicado: (1992)

Aggregation of M3 (E376D) variant of alpha1- antitrypsin
por: Bashir, Arif, et al.
Publicado: (2020)

Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture
por: Hu, Yanmei, et al.
Publicado: (2020)

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro
por: Gidari, Anna, et al.
Publicado: (2022)

The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract
por: Shi, Yuejun, et al.
Publicado: (2021)

Facade repair works on building 376
Publicado: (2003)

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
por: Ma, Chunlong, et al.
Publicado: (2020)

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
por: Ma, Chunlong, et al.
Publicado: (2020)

Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
por: Cáceres, C. Joaquín, et al.
Publicado: (2021)

MED12/376: Microbiology and the Hospital Intranet
por: Perera, B
Publicado: (1999)

Draft Genome Sequences of Paenibacillus polymyxa NRRL B-30509 and Paenibacillus terrae NRRL B-30644, Strains from a Poultry Environment That Produce Tridecaptin A and Paenicidins
por: van Belkum, Marco J., et al.
Publicado: (2015)

SARS-CoV-2 3CL(pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
por: Heilmann, Emmanuel, et al.
Publicado: (2022)

Run 376, Ring 2, 5C26, 29 October 1973: Neutralization pocket in magnet D746 and observation of clearing current I8
por: Gröbner, Oswald
Publicado: (1973)

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir
por: Xia, Zilei, et al.
Publicado: (2021)

P376: Dirty bedpans and MDRO: partners in crime?
por: Van Knippenberg-Gordebeke, GG
Publicado: (2013)

Competitive Binding of a Benzimidazole to the Histone-Binding Pocket of the Pygo PHD Finger
por: Miller, Thomas C. R., et al.
Publicado: (2014)

Asymmetric interactions in the adenosine-binding pockets of the MS2 coat protein dimer
por: Powell, Amy J, et al.
Publicado: (2001)

Violin sonatas K 378, K 376 & K 296
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1987)

MIR376A Is a Regulator of Starvation-Induced Autophagy
por: Korkmaz, Gozde, et al.
Publicado: (2013)

376. COVID-19 Severity in HIV+ Patients Receiving Tenofovir
por: Homsi, Nora, et al.
Publicado: (2020)

THU376 Isotretinoin Related DKA In Type 2 Diabetes
por: Radovanovic, Natasa, et al.
Publicado: (2023)

Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M(pro)
por: Niu, Chunying, et al.
Publicado: (2008)

Combined Subdermal Pocket Procedure and Abdominal Flap for Distal Finger Amputations in a Toddler
por: Tsai, Po-Lun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qcj9tvmcr8o7cfe1qlilm49102